文献速递间质性肺疾病呼吸危重症与机械通气

特发性肺纤维化急性加重对肺移植结局的影响

Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
PubMed 文献 · Chest · 2018-06-30

单中心2012-2016年89例等待肺移植的IPF患者中,52例稳定期移植,37例因AE-IPF住院(9例移植前死亡),28例急性加重期移植。移植后1年和3年生存率分别为71%、60% vs 94%、90%(P=.0001)。LAS>80者3年死亡风险比为5.7(95%CI 2.33-14.0;P<.0005)。

要点

  • AE-IPF期间肺移植的短期和长期生存均显著劣于稳定期移植。
  • LAS>80的AE-IPF患者可能无法获得预期的肺移植生存获益。
  • AE-IPF住院等待移植者中部分在移植前死亡,需权衡时机。

核心结论

  • AE-IPF期间接受肺移植的患者短期和长期生存显著差于稳定期IPF移植患者。
  • AE-IPF且LAS很高的患者可能无法获得肺移植预期的生存优势。

研究设计与样本

  • 单中心回顾性队列,纳入2012至2016年连续列入肺移植等待名单的89例IPF患者。
  • 收集肺分配评分(LAS)、住院和生存数据,主要结局为稳定期IPF与AE-IPF期间移植者的生存比较。

主要发现

  • 89例中52例稳定期移植,37例因AE-IPF住院,其中9例移植前死亡、28例AE-IPF期间移植。
  • 移植后1年和3年生存率:稳定期移植者94%和90%,AE-IPF移植者71%和60%(P=.0001)。
  • LAS>80者3年死亡风险比为5.7(95%CI 2.33-14.0;P<.0005),参照LAS<80。

临床怎么用

  • 评估AE-IPF患者肺移植时应告知其移植后生存率低于稳定期IPF移植。
  • 对AE-IPF且LAS>80者需谨慎评估移植预期获益。

局限性

  • 单中心回顾性研究,样本量有限。
  • AE-IPF住院患者中部分未移植即死亡,可能影响移植后结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has an expected median survival of 3 months. Lung transplantation is a potentially lifesaving therapy for AE-IPF. However, the current knowledge of transplantation outcomes during AE-IPF is limited to a few small retrospective studies, reporting only 1-year post-transplantation survival. METHODS: Study population included patients with IPF consecutively listed for lung transplantation at a single institution between the years 2012 and 2016. We collected lung allocation score (LAS), hospitalization, and survival data. The primary outcome was survival among patients transplanted during stable IPF vs during AE-IPF. RESULTS: Of 89 patients with IPF listed for lung transplantation, 52 were transplanted during stable IPF and 37 were hospitalized due to AE-IPF. Of these 37 patients, nine died before transplantation, and 28 were transplanted during AE-IPF. Fifty percent of patients transplanted during AE-IPF died in a mean follow-up of 1.6 ± 1.2 years compared with 12% of patients transplanted during stable IPF who died in a mean follow-up of 2.6 ± 1.2 years. The Kaplan-Meier survival curves post-transplantation after 1 and 3 years for patients who were transplanted during stable IPF were 94% and 90% vs 71% and 60% in patients who were transplanted during AE-IPF (P = .0001). LAS above 80 conferred a 3-year hazard ratio for mortality of 5.7 vs LAS lower than 80 (95% CI, 2.33-14.0; P < .0005). CONCLUSIONS: Patients with IPF transplanted during AE-IPF had significantly worse short-term and long-term survival compared with patients transplanted during stable IPF. Patients with AE-IPF and very high LAS may not experience the survival advantage expected from lung transplantation.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Dotan Y, Vaidy A, Shapiro WB, et al. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome. Chest. 2018. PMID: 29966665. doi:10.1016/j.chest.2018.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。